Nov 21, 2019 / 10:40AM GMT
Brandon Couillard - Jefferies LLC, Research Division - Equity Analyst
All right. We'll go ahead and get started. Thanks. Good morning. Welcome to Jefferies' 2019 London Healthcare Conference. I'm Brandon Couillard. I cover the life science, tools and diagnostics sector here at the firm. Very happy to have Exact Sciences with us back at the conference this year.
And here to share an update with us, Mr. Jeff Elliott, CFO; as well as Megan Jones, who heads up the IR, in the audience with us as well.
I'll turn it over to Jeff to make a few intro remarks and then we'll jump to the Q&A. Jeff?
Jeffrey T. Elliott - Exact Sciences Corporation - CFO
Thank you, Brandon. It's great to be back here, and thank you all for coming. Before we begin, a few quick words from our attorneys here, who find a way to fit 2,000 words under one slide.
At Exact, we're focused on the early detection and prevention of cancer. The reason why that's so important is that in cancer, many companies are focused on the end stages of life. Oftentimes, cancer drugs
Exact Sciences Corp at Jefferies London Healthcare Conference Transcript
Nov 21, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers